317
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Predictive value of symptoms for quality of life in first-episode schizophrenia

, M.B.B.S., M.D., , M.B.B.S., M.D., , M.B.B.S., M.D. & , M.B.B.S., M.D.
Pages 153-158 | Published online: 16 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Andrea de Bartolomeis, Andrea Fagiolini, Marco Vaggi & Claudio Vampini. (2016) Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics. Neuropsychiatric Disease and Treatment 12, pages 99-108.
Read now

Articles from other publishers (12)

Zhen Mao, Lu Tian, Yue Sun, Fang Dong, Chuanyue Wang & Qijing Bo. (2023) Quality of life and its predictors in first-episode schizophrenia and individuals at clinical high-risk for psychosis. BMC Psychiatry 23:1.
Crossref
Sally Mustafa, Ashok Malla, Greeshma Mohan, Ramachandran Padmavati, Thara Rangaswamy, Ridha Joober, Norbert Schmitz, Howard Margolese & Srividya N. Iyer. (2023) Subjective quality of life among first-episode psychosis patients in Chennai, India and Montreal, Canada. Schizophrenia Research 257, pages 41-49.
Crossref
Selma Ercan Doğu & Sibel Örsel. (2022) The relationship between psychopathology, occupational balance, and quality of life among people with schizophrenia. Australian Occupational Therapy Journal 70:3, pages 314-326.
Crossref
Xiao-Yan He, Christine Migliorini, Zhuo-Hui Huang, Fei Wang, Rui Zhou, Zi-Lang Chen, Yao-Nan Xiao, Qian-Wen Wang, Shi-Bin Wang, Carol Harvey & Cai-Lan Hou. (2022) Quality of life in patients with schizophrenia: A 2-year cohort study in primary mental health care in rural China. Frontiers in Public Health 10.
Crossref
Candice Tze Kwan Kam, Wing Chung Chang, Vivian Wing Yan Kwong, Emily Sin Ki Lau, Gloria Hoi Kei Chan, Olivia Tsz Ting Jim, Christy Lai Ming Hui, Sherry Kit Wa Chan, Edwin Ho Ming Lee & Eric Yu Hai Chen. (2021) Patterns and predictors of trajectories for subjective quality of life in patients with early psychosis: Three-year follow-up of the randomized controlled trial on extended early intervention. Australian & New Zealand Journal of Psychiatry 55:10, pages 983-992.
Crossref
Mei San Ang, Milawaty Nurjono & Jimmy Lee. (2019) The effects of clinical illness severity and physical activity on health-related quality of life in schizophrenia. Quality of Life Research 28:6, pages 1509-1520.
Crossref
Philip Watson, Jian-Ping Zhang, Asra Rizvi, Jonathan Tamaiev, Michael L. Birnbaum & John Kane. (2018) A meta-analysis of factors associated with quality of life in first episode psychosis. Schizophrenia Research 202, pages 26-36.
Crossref
Stefanie J. Schmidt, Matthias Lange, Daniel Schöttle, Anne Karow, Benno G. Schimmelmann & Martin Lambert. (2017) Negative symptoms, anxiety, and depression as mechanisms of change of a 12-month trial of assertive community treatment as part of integrated care in patients with first- and multi-episode schizophrenia spectrum disorders (ACCESS I trial). European Archives of Psychiatry and Clinical Neuroscience 268:6, pages 593-602.
Crossref
Kun-Po Chen & For-Wey Lung. (2017) Reliability and Validity of the Short Version of Udvalg for Kliniske Undersogelser in Antipsychotic Treatment. Psychiatric Quarterly 88:4, pages 787-796.
Crossref
Santosh K. Chaturvedi, M. Krishna Prasad & Abhishek Pathak. 2016. Beyond Assessment of Quality of Life in Schizophrenia. Beyond Assessment of Quality of Life in Schizophrenia 197 215 .
Parmanand Kulhara, Sandeep Grover & Natasha Kate. 2015. Developments in Psychiatry in India. Developments in Psychiatry in India 139 171 .
Aurigena Antunes de Araújo, Diego de Araújo Dantas, Gemma Galgani do Nascimento, Susana Barbosa Ribeiro, Katarina Melo Chaves, Vanessa de Lima Silva, Raimundo Fernandes de AraújoJr.Jr., Dyego Leandro Bezerra de Souza & Caroline Addison Carvalho Xavier de Medeiros. (2014) Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs. Psychiatric Quarterly 85:3, pages 357-367.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.